Skip to main content
. 2023 Jan 10;15:1098766. doi: 10.3389/fnmol.2022.1098766

Figure 1.

Figure 1

Study outline, sample workflow and clinical outcomes before and after 4-week treatment. (A) The detailed process of screening, enrollment, randomization, and treatment. (B) Workflow from sample collection to exosome identification, small RNA sequencing and bioinformatics analysis. (C) Clinical outcomes of trAMWoA and shAMWoA in baseline and after 4-week treatment. * represents p < 0.05, ** represents p < 0.01. HCs, healthy controls; trAMWoA, migraine without aura patients receiving true acupuncture treatment; shAMWoA, migraine without aura patients receiving sham acupuncture treatment; TA, true acupuncture; SA, sham acupuncture; NTA, nanoparticle tracking analysis; TEM, transmission electron microscopy; WB, western blotting; VAS, visual analogue scale; Headache Impact Test-6 scale, HIT-6; MSQ, migraine-specific quality of life questionnaire; MWoA, migraine without aura.